Cite
Goserelin plus tamoxifen compared to chemotherapy followed by tamoxifen in premenopausal patients with early stage-, lymph node-negative breast cancer of luminal A subtype.
MLA
Alramadhan, Mansoor, et al. “Goserelin plus Tamoxifen Compared to Chemotherapy Followed by Tamoxifen in Premenopausal Patients with Early Stage-, Lymph Node-Negative Breast Cancer of Luminal A Subtype.” Breast (Edinburgh, Scotland), vol. 30, Dec. 2016, pp. 111–17. EBSCOhost, https://doi.org/10.1016/j.breast.2016.08.011.
APA
Alramadhan, M., Ryu, J. M., Rayzah, M., Nam, S. J., Kim, S. W., Yu, J., Lee, S. K., Bae, S. Y., Park, S., Paik, H.-J., & Lee, J. E. (2016). Goserelin plus tamoxifen compared to chemotherapy followed by tamoxifen in premenopausal patients with early stage-, lymph node-negative breast cancer of luminal A subtype. Breast (Edinburgh, Scotland), 30, 111–117. https://doi.org/10.1016/j.breast.2016.08.011
Chicago
Alramadhan, Mansoor, Jai Min Ryu, Musaed Rayzah, Seok Jin Nam, Seok Won Kim, Jonghan Yu, Se Kyung Lee, et al. 2016. “Goserelin plus Tamoxifen Compared to Chemotherapy Followed by Tamoxifen in Premenopausal Patients with Early Stage-, Lymph Node-Negative Breast Cancer of Luminal A Subtype.” Breast (Edinburgh, Scotland) 30 (December): 111–17. doi:10.1016/j.breast.2016.08.011.